WuXi AppTec Co., Ltd, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, recently provided updates to investors on the status of its A-share repurchase and H-share acquisition activities in Q2 2025.

The Company repurchased and cancelled RMB1.0 billion worth of A-share to enhance shareholder value, and instructed the trustee (the "Scheme Trustee") of its 2025 H Share Award and Trust Scheme to acquire HKD2.5 billion worth of H-share for the purpose of attracting and retaining highly talented employees.

Here is a full update on both programs:  

Update on A-Share Repurchase and Cancellation:

• On April 8, 2025, the Company's Board of Directors approved an RMB1.0 billion A-share repurchase and cancellation program. It took this action to uphold the Company's value and protect the interests of shareholders.
• From April 18, 2025 to June 20, 2025, WuXi AppTec spent RMB1.0 billion (exclusive of transaction fees) to buy an aggregate of 15,775,377 A Shares (representing approximately 0.55% of the Company's total issued share capital as of June 23, 2025) at an average price of RMB63.39 per share.
• On June 24, 2025, WuXi AppTec completed cancellation of all A Shares repurchased under this program.
• For more information, please refer to the Company's relevant announcement:
  • June 23, 2025: Announcement of the completion of the repurchase of A Shares of the Company for the second time In 2025 and cancellation of A Shares of the Company.

Update on H-Share Acquisition:

• As of June 27, 2025, the Company instructed the Scheme Trustee to complete the acquisition of HKD2.5 billion worth of H Shares through on-market transactions for the purpose of the 2025 H Share Award and Trust Scheme, with an aggregate of 34,092,975 H shares acquired (representing approximately 1.19% of the Company's total issued share capital as of June 30, 2025), and will not result in dilution to existing shareholders.
• These acquired H shares will be used to continuously attract and retain top talents, strengthen the collective capabilities of management team, and enhance the resilience of the Company's business operations and management.
• According to the 2025 H Share Award and Trust Scheme:
  • No more than HKD1.5 billion worth of H shares will be granted to the selected employees upon the Company's 2025 revenue achieving at least RMB42.0 billion.
  • An additional HKD1.0 billion worth of H shares (and thus a total of HKD2.5 billion worth of H shares) will be granted to the selected employees upon the Company's 2025 revenue achieving at least RMB43.0 billion.
• For more information, please refer to the Company's relevant announcements:
  • June 13, 2025: Completion of the acquisition of H shares by the Scheme Trustee in the amount of HK$1.5 billion under the basic condition of grant of the 2025 H Share Award and Trust Scheme.
  • June 30, 2025: Completion of the acquisition of H shares by the Scheme Trustee in the amount of HK$1 billion under the additional condition of grant of the 2025 H Share Award and Trust Scheme.